157 related articles for article (PubMed ID: 33649373)
21. Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data.
Xiong Y; Deng Y; Wang K; Zhou H; Zheng X; Si L; Fu Z
EBioMedicine; 2018 Oct; 36():183-195. PubMed ID: 30243491
[TBL] [Abstract][Full Text] [Related]
22. Survival-associated alternative splicing signatures in non-small cell lung cancer.
Zhao D; Zhang C; Jiang M; Wang Y; Liang Y; Wang L; Qin K; Rehman FU; Zhang X
Aging (Albany NY); 2020 Apr; 12(7):5878-5893. PubMed ID: 32282333
[TBL] [Abstract][Full Text] [Related]
23. Profiles of prognostic alternative splicing signature in hepatocellular carcinoma.
Wu F; Chen Q; Liu C; Duan X; Hu J; Liu J; Cao H; Li W; Li H
Cancer Med; 2020 Mar; 9(6):2171-2180. PubMed ID: 31975560
[TBL] [Abstract][Full Text] [Related]
24. Characterization of alternative splicing events and prognostic signatures in breast cancer.
Han P; Zhu J; Feng G; Wang Z; Ding Y
BMC Cancer; 2021 May; 21(1):587. PubMed ID: 34022836
[TBL] [Abstract][Full Text] [Related]
25. A novel alternative splicing-based prediction model for uteri corpus endometrial carcinoma.
Gao L; Xie ZC; Pang JS; Li TT; Chen G
Aging (Albany NY); 2019 Jan; 11(1):263-283. PubMed ID: 30640723
[TBL] [Abstract][Full Text] [Related]
26. Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas.
Fluge O; Haugen DR; Akslen LA; Marstad A; Santoro M; Fusco A; Varhaug JE; Lillehaug JR
Oncogene; 2001 Feb; 20(7):885-92. PubMed ID: 11314023
[TBL] [Abstract][Full Text] [Related]
27. Alternative Splicing Events and Splicing Factors Are Prognostic in Adrenocortical Carcinoma.
Lv J; He Y; Li L; Wang Z
Front Genet; 2020; 11():918. PubMed ID: 33101358
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of LncRNA HOTAIR is Associated with Poor Prognosis in Thyroid Carcinoma: A Study Based on TCGA and GEO Data.
Li HM; Yang H; Wen DY; Luo YH; Liang CY; Pan DH; Ma W; Chen G; He Y; Chen JQ
Horm Metab Res; 2017 May; 49(5):388-399. PubMed ID: 28351094
[TBL] [Abstract][Full Text] [Related]
29. An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors.
Wang Y; Wang Y; Li K; Du Y; Cui K; Yu P; Zhang T; Liu H; Ma W
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33000861
[TBL] [Abstract][Full Text] [Related]
30. Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma.
Chen T; Zheng W; Chen J; Lin S; Zou Z; Li X; Tan Z
J Cell Biochem; 2020 Oct; 121(10):4074-4084. PubMed ID: 31886566
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of long intergenic noncoding RNA LINC00312 inhibits the invasion and migration of thyroid cancer cells by down-regulating microRNA-197-3p.
Liu K; Huang W; Yan DQ; Luo Q; Min X
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28539331
[TBL] [Abstract][Full Text] [Related]
32. Identification of a prognostic alternative splicing signature in oral squamous cell carcinoma.
Zhang S; Wu X; Diao P; Wang C; Wang D; Li S; Wang Y; Cheng J
J Cell Physiol; 2020 May; 235(5):4804-4813. PubMed ID: 31637730
[TBL] [Abstract][Full Text] [Related]
33. Expression of UGT2B7 is driven by two mutually exclusive promoters and alternative splicing in human tissues: changes from prenatal life to adulthood and in kidney cancer.
Ménard V; Lévesque E; Chen S; Eap O; Joy MS; Ekström L; Rane A; Guillemette C
Pharmacogenet Genomics; 2013 Dec; 23(12):684-96. PubMed ID: 24128937
[TBL] [Abstract][Full Text] [Related]
34. Identification of candidates for tumor-specific alternative splicing in the thyroid.
Guimarães GS; Latini FR; Camacho CP; Maciel RM; Dias-Neto E; Cerutti JM
Genes Chromosomes Cancer; 2006 Jun; 45(6):540-53. PubMed ID: 16493598
[TBL] [Abstract][Full Text] [Related]
35. The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer.
Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
Aging (Albany NY); 2021 Jan; 13(3):4317-4334. PubMed ID: 33428603
[TBL] [Abstract][Full Text] [Related]
36. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data.
Zhou YJ; Zhu GQ; Zhang QW; Zheng KI; Chen JN; Zhang XT; Wang QW; Li XB
DNA Cell Biol; 2019 Nov; 38(11):1207-1222. PubMed ID: 31483163
[TBL] [Abstract][Full Text] [Related]
37. SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes.
Song X; Wan X; Huang T; Zeng C; Sastry N; Wu B; James CD; Horbinski C; Nakano I; Zhang W; Hu B; Cheng SY
Cancer Res; 2019 Oct; 79(20):5288-5301. PubMed ID: 31462429
[TBL] [Abstract][Full Text] [Related]
38. Transcriptome-wide analysis of alternative mRNA splicing signature in the diagnosis and prognosis of stomach adenocarcinoma.
Shi Y; Chen Z; Gao J; Wu S; Gao H; Feng G
Oncol Rep; 2018 Oct; 40(4):2014-2022. PubMed ID: 30106437
[TBL] [Abstract][Full Text] [Related]
39. Systematic Profiling of mRNA Splicing Reveals the Prognostic Predictor and Potential Therapeutic Target for Glioblastoma Multiforme.
Zhang B; Wu Q; Cheng S; Li W
J Oncol; 2021; 2021():4664955. PubMed ID: 34326872
[TBL] [Abstract][Full Text] [Related]
40. Systematic profiling of alternative splicing signature reveals prognostic predictor for prostate cancer.
Zhao J; Chang L; Gu X; Liu J; Sun B; Wei X
Cancer Sci; 2020 Aug; 111(8):3020-3031. PubMed ID: 32530556
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]